Rare diseases
Investigational molecules
Locations
Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
PolandStudy of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer
PolandStudy on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria
PolandStudy of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer
PolandStudy to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment
PolandStudy on Radiprodil for Seizures and Behavioral Symptoms in Patients with Tuberous Sclerosis Complex or Focal Cortical Dysplasia Type II
PolandStudy on the Effects of Trimetazidine on Heart Failure with Preserved Ejection Fraction in Patients
PolandStudy of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy
PolandStudy of BMS-986158 Alone and with Ruxolitinib or Fedratinib for Patients with Intermediate or High Risk Myelofibrosis
PolandStudy of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma
PolandStudy of BMS-986315 and Nivolumab with Chemotherapy for First-line Treatment in Stage IV or Recurrent Non-Small Cell Lung Cancer Patients
PolandStudy on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
